These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38901650)

  • 1. Pen2/ErbB4 signaling regulates stemness of pancreatic ductal carcinoma.
    Zhu Z; Ding D; Hu H; He T
    Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167316. PubMed ID: 38901650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
    Song W; Li Q; Wang L; Huang W; Wang L
    Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells.
    Mortoglou M; Miralles F; Arisan ED; Dart A; Jurcevic S; Lange S; Uysal-Onganer P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1-CD44 Axis.
    Nallasamy P; Nimmakayala RK; Karmakar S; Leon F; Seshacharyulu P; Lakshmanan I; Rachagani S; Mallya K; Zhang C; Ly QP; Myers MS; Josh L; Grabow CE; Gautam SK; Kumar S; Lele SM; Jain M; Batra SK; Ponnusamy MP
    Gastroenterology; 2021 Dec; 161(6):1998-2013.e7. PubMed ID: 34418441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes.
    Ai J; Wörmann SM; Görgülü K; Vallespinos M; Zagorac S; Alcala S; Wu N; Kabacaoglu D; Berninger A; Navarro D; Kaya-Aksoy E; Ruess DA; Ciecielski KJ; Kowalska M; Demir IE; Ceyhan GO; Heid I; Braren R; Riemann M; Schreiner S; Hofmann S; Kutschke M; Jastroch M; Slotta-Huspenina J; Muckenhuber A; Schlitter AM; Schmid RM; Steiger K; Diakopoulos KN; Lesina M; Sainz B; Algül H
    Gastroenterology; 2021 Jul; 161(1):318-332.e9. PubMed ID: 33819482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.
    Sasaki N; Toyoda M; Hasegawa F; Fujiwara M; Gomi F; Ishiwata T
    Biochem Biophys Res Commun; 2019 Jun; 514(1):112-117. PubMed ID: 31027735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.
    Maity G; Haque I; Ghosh A; Dhar G; Gupta V; Sarkar S; Azeem I; McGregor D; Choudhary A; Campbell DR; Kambhampati S; Banerjee SK; Banerjee S
    J Biol Chem; 2018 Mar; 293(12):4334-4349. PubMed ID: 29414775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma.
    Aboukameel A; Muqbil I; Senapedis W; Baloglu E; Landesman Y; Shacham S; Kauffman M; Philip PA; Mohammad RM; Azmi AS
    Mol Cancer Ther; 2017 Jan; 16(1):76-87. PubMed ID: 28062705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Nimmakayala RK; Leon F; Rachagani S; Rauth S; Nallasamy P; Marimuthu S; Shailendra GK; Chhonker YS; Chugh S; Chirravuri R; Gupta R; Mallya K; Prajapati DR; Lele SM; C Caffrey T; L Grem J; Grandgenett PM; Hollingsworth MA; Murry DJ; Batra SK; Ponnusamy MP
    Oncogene; 2021 Jan; 40(1):215-231. PubMed ID: 33110235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.
    Palagani V; El Khatib M; Kossatz U; Bozko P; Müller MR; Manns MP; Krech T; Malek NP; Plentz RR
    PLoS One; 2012; 7(10):e46514. PubMed ID: 23094026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.
    Zheng Q; Tang J; Aicher A; Bou Kheir T; Sabanovic B; Ananthanarayanan P; Reina C; Chen M; Gu JM; He B; Alcala S; Behrens D; Lawlo RT; Scarpa A; Hidalgo M; Sainz B; Sancho P; Heeschen C
    J Exp Clin Cancer Res; 2023 Nov; 42(1):323. PubMed ID: 38012687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma.
    Jo JH; Kim SA; Lee JH; Park YR; Kim C; Park SB; Jung DE; Lee HS; Chung MJ; Song SY
    BMC Cancer; 2021 Nov; 21(1):1241. PubMed ID: 34794402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability.
    Jiang W; Liu L; Wang M; Li X; Zhou T; Hou X; Qiao L; Chen C; Zuo D; Liu J; Ren L
    Cell Mol Life Sci; 2024 Oct; 81(1):417. PubMed ID: 39367978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.